ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Senators introduced legislation on Thursday that would ...

Teva Pharmaceutical is one of the leading global generic drug manufacturers. By our estimate, roughly 70% of its total revenue is derived from generics and off-patent branded drugs. Generic drugs in ...

Obrecht (Kathleen Gati) pays a visit to her daughter at work, but Britt (Kelly Thiebaud) tries to steer her plan in another direction. “Maybe we should show them that,” she suggests, “by doing the ...

What makes a moment memorable enough to shape the year ahead? For designers, inspiration doesn’t arrive on a predictable schedule—it strikes in a 17th-century Parisian atelier, at a student art show, ...

This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. The combination of Azul and Payara addresses some of the most pressing ...

In 2026, Novo Nordisk’s patent on semaglutide will expire in several countries, including India and China. Generic-drug makers are poised to flood these markets with inexpensive products. Industry ...

Artificial intelligence continues to reshape the digital landscape, and as we move into 2026, the pace of change is accelerating. Businesses across industries are leaning more heavily on AI software ...

When a Northern California couple with two young children acquired a pied-à-terre in Manhattan, there was no doubt about who could transform it into their fantasy New York escape. At the time, they ...

Incyte Corporation is undervalued, with high revenue growth, strong margins, and a 12.7% upside to a $115 target price; rated Buy. INCY's Q3 results beat expectations, driven by Jakafi and Opzelura ...

Trump administration officials pledged Monday that major reforms for biosimilar drug approvals will expand access and lower prices for some of the most expensive drugs on the market. The ...